🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 10 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/01/2025 19,24 19,62 18,97 19,56 +2,84% 3,38% 931.600
16/01/2025 18,89 19,06 18,35 19,02 +0,48% 3,76% 1.665.900
15/01/2025 18,55 19,19 18,29 18,93 +4,88% 4,85% 1.696.600
14/01/2025 19,04 19,07 18,02 18,05 -4,55% 5,51% 1.237.000
13/01/2025 18,42 18,98 17,75 18,91 +2,27% 6,68% 2.243.700
10/01/2025 19,18 19,41 18,10 18,49 -6,38% 6,83% 2.506.000
08/01/2025 19,32 20,78 19,32 19,75 +0,41% 7,56% 1.715.800
07/01/2025 19,48 20,48 19,43 19,67 +0,87% 5,42% 1.224.800
06/01/2025 19,79 20,30 19,16 19,50 -1,47% 5,79% 1.462.500
03/01/2025 19,67 20,54 19,56 19,79 +0,71% 5,01% 1.038.900
02/01/2025 18,94 19,94 18,66 19,65 +4,52% 6,75% 1.265.100
31/12/2024 18,78 19,23 18,25 18,80 +1,02% 5,22% 1.225.900
30/12/2024 18,86 19,03 18,40 18,61 -1,85% 3,34% 1.126.700
27/12/2024 19,45 20,11 18,87 18,96 -2,92% 6,38% 1.361.900
26/12/2024 19,31 19,80 19,10 19,53 -0,51% 3,60% 957.800
24/12/2024 19,78 19,94 19,10 19,63 -0,61% 4,22% 590.000
23/12/2024 19,50 19,95 19,36 19,75 +1,54% 3,05% 1.399.300
20/12/2024 19,38 20,21 19,18 19,45 -0,26% 5,31% 4.011.000
19/12/2024 20,32 20,35 19,21 19,50 -4,22% 5,61% 1.829.300
18/12/2024 22,27 22,28 20,12 20,36 -8,58% 9,70% 1.399.300
17/12/2024 22,04 22,46 21,70 22,27 -0,45% 3,43% 868.400
16/12/2024 21,68 22,47 21,48 22,37 +2,38% 4,57% 1.111.200
13/12/2024 21,96 22,18 21,51 21,85 -1,31% 3,05% 1.094.300
12/12/2024 22,65 22,98 21,85 22,14 -2,60% 4,99% 1.405.800
11/12/2024 23,92 24,25 22,61 22,73 -4,97% 6,86% 1.567.800
10/12/2024 23,31 23,94 22,93 23,92 +2,79% 4,33% 1.293.700
09/12/2024 23,67 23,94 23,19 23,27 -1,44% 3,17% 1.148.300
06/12/2024 22,43 24,03 22,26 23,61 +5,87% 7,89% 1.366.200
05/12/2024 22,95 23,20 22,06 22,30 -3,50% 4,97% 2.045.000
04/12/2024 26,15 26,38 22,87 23,11 -11,35% 13,44% 2.654.500